Summary Orgenesis Inc (Orgenesis) is a biopharmaceutical company that focuses on the development and manufacturing of regenerative cellular therapy and medicine for the treatment of insulin-dependent diabetes patients.The company, through its subsidiaries, offers contract development and manufacturing, and proprietary cell therapy development.
It also provides GMP manufacturing, process development, quality management and assay development, and other services.Orgenesis offers cell therapies for autoimmune, oncologic, neurologic and orthopedic diseases.
The company utilizes its proprietary technology to reprogram human liver cells into glucose-responsive insulin-producing cells to provide a practical cure for insulin-dependent diabetes. Orgenesis is headquartered in Germantown, Maryland, the US.
Orgenesis Inc (ORGS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The global cell isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9billion in 2020, at a CAGR of 16.8% during the forecast period. Market growth is driven by factors The growing investments in personalized medicine can primarily be attributed to the growing demand for advanced treatments with minimal side-effects...
The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period. The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide.. Growth in the market can primarily...
The Global Biosimilars Partnering Terms and Agreements 2010 to 2020 report provides an understanding and access to the Biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Biosimilars partnering deals Disclosed headlines, upfronts, milestones and royalties...
The Global Microbiome Partnering Terms and Agreements 2010 to 2020 report provides an understanding and access to the Microbiome partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Microbiome partnering deals Disclosed headlines, upfronts, milestones and royalties by...
The Europe Medical Thawing System Market would witness market growth of 10% CAGR during the forecast period (2020-2026). Modern thawing systems permit fast thawing while keeping tissue quality intact. Moreover, characteristics like space-saving design, visual heater indicator, LED digital temperature display, and audiovisual high-temperature...
The Asia Pacific Medical Thawing System Market would witness market growth of 12% CAGR during the forecast period (2020-2026). The region comprises of growing economies, significantly China, India, and Japan. These nations consist of a huge number of patients with a high chronic disease rate. A rise in the number of chronic diseases...
The Latin America, Middle East and Africa Medical Thawing System Market would witness market growth of 11.5% CAGR during the forecast period (2020-2026). The increasing number of surgeries and growing rates of hemorrhage-related conditions in these surgeries are boosting the growth of the medical thawing system. The demand for thawed...
The North America Medical Thawing System Market would witness market growth of 9.8% CAGR during the forecast period (2020-2026). Thawing can be considered as a process of taking a frozen item from frozen to a temperature (generally above 00C) where there is no remaining ice viz. defrosting. Thawing is frequently considered as merely...
82 pages •
By Asia Market Information & Development Company
• Apr 2021
This study focuses on BiologicsChina’s industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...
The global CDMO market is estimated to reach US$241.3 billion in 2024, growing at a CAGR of 9.80% for the period spanning from 2020 to 2024. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.